|
WASHINGTON (AP) - House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical experts to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
Democratic leaders of the House Energy and Commerce Committee sent a letter to the companies Friday asking why minutes from a November meeting about the blockbuster cholesterol drug were created after the fact, in December. The five-member panel of medical advisers were told that no minutes or transcript of the meeting would be taken, the lawmakers note.
Committee Chairman John Dingell and Subcommittee for Oversight Chairman Bart Stupak began investigating in December how Merck and Schering-Plough handled data comparing Merck's Zocor against their new cholesterol drug Vytorin.
|